N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis
- 13 March 2000
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 112-113, 349-356
- https://doi.org/10.1016/s0378-4274(99)00226-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Pitfalls in N-acetyltransferase 2 genotypingPharmacogenetics, 1999
- Functional polymorphism of the human arylamine JV-acetyltransferase type 1 gene caused by C190T and G560A mutationsPharmacogenetics, 1998
- Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer.Carcinogenesis: Integrative Cancer Research, 1998
- Higher Frequency of Aberrant Crypt Foci in Rapid Than Slow Acetylator Inbred Rats Administered the Colon Carcinogen 3,2′-Dimethyl-4-aminobiphenylToxicology and Applied Pharmacology, 1997
- Human acetyltransferase polymorphismsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesisBiochemical Journal, 1997
- Identification of a Novel Allele at the HumanNAT1Acetyltransferase LocusBiochemical and Biophysical Research Communications, 1997
- Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli.Journal of Biological Chemistry, 1994
- Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymesHuman Molecular Genetics, 1994
- Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferasesCarcinogenesis: Integrative Cancer Research, 1993